Clinical Trials Browser

Active not recruiting × Blood Specimen Collection × Breast × Clear all

NCT02453620 2026-03-18

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 1 Active not recruiting

BreastOther solid neoplasm

Anatomic Stage III Breast Cancer AJCC v8

NCT04454528 2026-03-10

BreastVAX

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT07421479 2026-02-19

PDO-Mercurial

Active not recruiting

Triple Negative Breast Neoplasms

NCT03424915 2026-02-04

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Active not recruiting

Breast Neoplasms

NCT03731845 2025-11-20

ESIGON

Phase NA Active not recruiting

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT04067726 2025-10-16

TRIDENT

Phase 2 Active not recruiting

Breast Neoplasms

NCT02743910 2025-07-17

Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

Active not recruiting

Breast Neoplasms

NCT01953159 2025-06-08

Assessment of Paclitaxel-Induced Neuropathy

Active not recruiting

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00903591 2025-06-03

Study of Radiation Exposure and Bilateral Breast Cancer

Active not recruiting

Breast Neoplasms, Neoplasms

NCT04331067 2025-04-23

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Phase 1/2 Active not recruiting

15 enrolled 12 charts

Triple Negative Breast Neoplasms

NCT03252717 2025-04-02

BIORISE

Phase NA Active not recruiting

Breast Neoplasms